Profiel
Craig West worked as Research Director at Guggenheim Partners LLC from 2004 to 2015.
Served as Senior Director-Investor Relations at BeOne Medicines Ltd. from 2018 to 2021.
Held the position of Senior Vice President-Investor Relations at Nanobiotix SA. Worked as Partner at A.G.
Edwards & Sons, Inc. Held the role of Vice President-Investor Relations at Epizyme, Inc. in 2021.
Served as Vice President-Investor Relations & Communications at Curis, Inc. in 2022.
Eerdere bekende functies van Craig West
| Bedrijven | Functie | Einde |
|---|---|---|
| NANOBIOTIX | Investor Relations Contact | 01-05-2025 |
| CURIS, INC. | Investor Relations Contact | 01-11-2022 |
| EPIZYME, INC. | Investor Relations Contact | 01-11-2021 |
| BEIGENE LTD | Investor Relations Contact | 01-03-2021 |
Guggenheim Partners LLC
Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Hoofd Techniek/Wetenschap/O&O | 01-05-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
A.G. Edwards & Sons, Inc.
A.G. Edwards & Sons, Inc. Investment Banks/BrokersFinance Provides brokerage dealing services | Finance |
Curis, Inc.
Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Guggenheim Partners LLC
Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Finance |
Nanobiotix SA
Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
















